CDH1 and metastatic malignant neoplasm in the lymph nodes: (32) confirmed that methylation in the CDH1 gene promoter region might cause a reduction in CDH1 expression, and BRCA patients with lower CDH1 expression were more prone to lymph node metastasis and experienced lower OS rate and shorter disease-free survival.